Technical Analysis for XDNA - iShares Genomics Immunology and Healthcare ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 1.48% | |
| Bollinger Band Squeeze | Range Contraction | 1.48% | |
| Narrow Range Bar | Range Contraction | 1.48% | |
| Gapped Up | Strength | 1.48% | |
| Overbought Stochastic | Strength | 1.48% | |
| Bollinger Band Squeeze | Range Contraction | 2.60% | |
| Narrow Range Bar | Range Contraction | 2.60% | |
| Stochastic Reached Overbought | Strength | 2.60% | |
| Overbought Stochastic | Strength | 2.60% | |
| Gapped Down | Weakness | 2.60% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 12 days ago |
| Up 1% | 12 days ago |
| Rose Above Previous Day's High | 15 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
iShares Genomics Immunology and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. The fund is managed by BlackRock Fund Advisors. It invests in public equity markets of global region. It invests in stocks of companies operating across health care, health care equipment and services, pharmaceuticals, biotechnology and life sciences sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index, by using representative sampling technique. iShares Genomics Immunology and Healthcare ETF was formed on June 11, 2019 and is domiciled in the United States.
Keywords: Exchange Traded Funds Financial Markets Ishares Blackrock Spdr Synthetic Replication Biotechnology Pharmaceuticals Black Rock Fund
Classification
Keywords: Exchange Traded Funds Financial Markets Ishares Blackrock Spdr Synthetic Replication Biotechnology Pharmaceuticals Black Rock Fund
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 44.949 |
| 52 Week Low | 24.8476 |
| Average Volume | 1,295 |
| 200-Day Moving Average | 0.000 |
| 50-Day Moving Average | 33.514 |
| 20-Day Moving Average | 34.384 |
| 10-Day Moving Average | 34.356 |
| Average True Range | 0.509 |
| RSI (14) | 57.63 |
| ADX | 10.06 |
| +DI | 46.729 |
| -DI | 38.824 |
| Chandelier Exit (Long, 3 ATRs) | 34.044 |
| Chandelier Exit (Short, 3 ATRs) | 35.096 |
| Upper Bollinger Bands | 35.389 |
| Lower Bollinger Band | 33.379 |
| Percent B (%b) | 0.83 |
| BandWidth | 5.845 |
| MACD Line | 0.345 |
| MACD Signal Line | 0.338 |
| MACD Histogram | 0.0079 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 35.050 | ||||
| Resistance 3 (R3) | 35.050 | 35.050 | 35.050 | ||
| Resistance 2 (R2) | 35.050 | 35.050 | 35.050 | 35.050 | |
| Resistance 1 (R1) | 35.050 | 35.050 | 35.050 | 35.050 | 35.050 |
| Pivot Point | 35.050 | 35.050 | 35.050 | 35.050 | 35.050 |
| Support 1 (S1) | 35.050 | 35.050 | 35.050 | 35.050 | 35.050 |
| Support 2 (S2) | 35.050 | 35.050 | 35.050 | 35.050 | |
| Support 3 (S3) | 35.050 | 35.050 | 35.050 | ||
| Support 4 (S4) | 35.050 |
